- Our Services
-
Patients and Families
- Get Directions
- Parking
- Childrens Locations
- Getting Around
- Guidelines for Visitors
- Contact a Patient
- Contact Children's
- Send an e-Card
- Gift Shop
Planning a Visit
- Find a Doctor
- Child Health A-Z
- Community Ed.Classes
- Injury Prevention
- International Patients
- Medical Records
- Patient Handbook
- Patient Procedures
Parents
- For Health Professionals
- Research
- Ways to Give
-
News
-
Adding Breast Milk Ingredient to Formula Could Prevent Deadly Intestinal Problem in Premature Babies
-
Children's Holds Groundbreaking Ceremony for Expansion to New South Fayette Location
-
Child Neurodevelopmental and Mental Health Disabilities on the Rise, Study Finds
News Releases
-
Research
Study for Infants with Biliary Atresia
A Randomized, Double-Blind, Placebo-Controlled Trial of Corticosteroid Therapy Following Portoenterostomy in Infants with Biliary Atresia
Protocol Description
The purpose of this study is to evaluate whether perioperative treatment with corticosteroids improves the outcome of infants following Kasai surgery for biliary atresia. Even after the Kasai operation, which removes scarred bile ducts, about 1 out of 2 patients will have severe liver damage by age 2 and may require a liver transplant. This research will help determine whether corticosteroid therapy can improve bile drainage and help prevent liver failure following the Kasai operation without causing serious side effects from the steroid medication itself.
This study is being conducted through the Childhood Liver Disease Research and Education Network (ChiLDREN), a network of 15 clinical sites in the United States and Canada.
Eligibility Criteria
All infants with biliary atresia up through 6 months of age who are scheduled to have Kasai surgery, or who have had Kasai surgery within the past 72 hours.
Boys: Newborn through 6 months
Girls: Newborn through 6 months
Requirements
Participants need to be enrolled in the Prospective Database of Infants with Cholestasis to be eligible for this study. Participants will randomly be placed into one of two groups. One group will receive the corticosteroid medication and the other group will receive a placebo. The study medication will be administered for 13 weeks following Kasai surgery, and participants will be examined at their regular follow-up clinic visits, usually scheduled at 1, 2, 3 and 6 months after surgery and then at 12, 18 and 24 months of age. An extra visit at 2 weeks after surgery also is required. Blood samples will be taken at the same time blood is drawn as part of the patient’s usual care following the Kasai operation. Parents/guardians keep a medical diary of the child’s condition during the study period.
Visits: 8
Duration: 24 months
Status: Open for Enrollment
Source of Support
National Institutes of Health
Additional Resources
Kasai Procedure
Biliary Atresia
Description of this study at the National Institutes of Health Web Site
Primary Investigator(s)
Benjamin L. Shneider, MD
Contact Information
To get started, please contact:
Beverly Bernard, CRNP
412-692-5811
Last Update
May 5, 2010
May 5, 2010
